Stefanie Ferreri

Ferreri Promoted to Clinical Professor

March 10, 2017

Stefanie Ferreri, Pharm.D., executive vice chair of the Division of Practice Advancement and Clinical Education, has been promoted to the rank of clinical professor. Ferreri joined the UNC Eshelman School of Pharmacy as a clinical assistant professor in 2001 and … Continued

kristy ainslie 600x400

Kristy Ainslie Receives Tenure in DPMP

February 22, 2017

Kristy Ainslie, Ph.D., an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, has been granted tenure. Ainslie joined the School in 2014. Prior to that, she spent almost five years as … Continued


Bush Awarded 2017 AACP New Investigator Award

February 1, 2017

Antonio Bush, Ph.D., is the recipient of a 2017 American Association of Colleges of Pharmacy New Investigator Award, a grant of up to $10,000 that provides start-up funding to early-career pharmacy faculty for independent research programs. Recipients also receive a … Continued


Dusetzina Named to National Academies Report Committee

January 9, 2017

Stacie Dusetzina, Ph.D., has been confirmed as a committee member for the National Academies of Sciences, Engineering and Medicine report titled “Ensuring Patient Access to Affordable Drug Therapies.” The committee is charged by the National Academy of Medicine (formerly the … Continued

Harold Kohn

Kohn Named Fellow of the National Academy of Inventors

January 6, 2017

Harold “Hal” Kohn, Ph.D., professor emeritus of the UNC Eshelman School of Pharmacy has been named a fellow of the National Academy of Inventors. The NAI Fellows Selection Committee chooses candidates who have demonstrated “a highly prolific spirit of innovation … Continued


Eckel, Ferreri Recognized at 2016 NCAP Convention

November 21, 2016

UNC Eshelman School of Pharmacy faculty members Stephen Eckel, Pharm.D., M.H.A., and Stefanie Ferreri, Pharm.D., were recognized by the North Carolina Association of Pharmacists at its 2016 Convention. Eckel, the president of NCAP, was presented with the President’s Award, and … Continued

E(I) lab students make a final presentation.

E(I) Lab Hosts Inaugural Final Presentations

October 28, 2016

The Carolina E(I) Lab, part of the Eshelman Institute for Innovation, concluded its pilot year by hosting final presentations from the inaugural cohort of student teams on Oct. 1, with the top four teams awarded monetary prizes. The presentations were … Continued


Antonio Bush Joins PACE as Assistant Professor

October 20, 2016

Antonio Bush, Ph.D., has joined the UNC Eshelman School of Pharmacy as an assistant professor of educational innovation and research on the tenure track in the Division of Practice Advancement and Clinical Education. He is also an assistant director of … Continued


Sachiko Ozawa Joins PACE as Associate Professor

October 17, 2016

Sachiko Ozawa, Ph.D., M.H.S., has joined the UNC Eshelman School of Pharmacy as an associate professor in the Division of Practice Advancement and Clinical Education. Ozawa’s principal research interests are in global health economics and outcomes, including estimating the value … Continued


Unvaccinated Adults Cost the U.S. More than $7 Billion a Year

October 12, 2016

Vaccine-preventable diseases among adults cost the U.S. economy $8.95 billion in 2015, and unvaccinated individuals are responsible for 80 percent, or $7.1 billion, of the tab, according to the most comprehensive analysis to date from the UNC Eshelman School of … Continued


Gauri Rao Joins DPET as Assistant Professor

October 11, 2016

Gauri Rao, Pharm.D., M.S., has joined the UNC Eshelman School of Pharmacy as a tenure-track assistant professor in the Division of Pharmacotherapy and Experiential Education. Rao’s principal research interests surround quantitative systems pharmacology, and she is working to understand the … Continued

Scientists in the CICBDD study biological "locks" in search of new keys to treating diseases, particularly cancer.

NCI Renews Partnership with UNC to Seek New Cancer Drugs

October 6, 2016

The University of North Carolina at Chapel Hill will pursue treatments for specific cancer targets as a specialized member of the National Cancer Institute’s renewed Experimental Therapeutics, or NExT, program through a contract with Leidos Biomed and its Frederick National … Continued